Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
Kevin M. Boehm,Emily A. Aherne,Lora Ellenson,Ines Nikolovski,Mohammed Alghamdi,Ignacio Vázquez-García,Dmitriy Zamarin,Kara Long Roche,Ying Liu,Druv Patel,Andrew Aukerman,Arfath Pasha,Doori Rose,Pier Selenica,Pamela I. Causa Andrieu,Chris Fong,Marinela Capanu,Jorge S. Reis-Filho,Rami Vanguri,Harini Veeraraghavan,Natalie Gangai,Ramon Sosa,Samantha Leung,Andrew McPherson,JianJiong Gao,Yulia Lakhman,Sohrab P. Shah,MSK MIND Consortium
DOI: https://doi.org/10.1038/s43018-022-00388-9
IF: 22.7
2022-06-29
Nature Cancer
Abstract:Patients with high-grade serous ovarian cancer suffer poor prognosis and variable response to treatment. Known prognostic factors for this disease include homologous recombination deficiency status, age, pathological stage and residual disease status after debulking surgery. Recent work has highlighted important prognostic information captured in computed tomography and histopathological specimens, which can be exploited through machine learning. However, little is known about the capacity of combining features from these disparate sources to improve prediction of treatment response. Here, we assembled a multimodal dataset of 444 patients with primarily late-stage high-grade serous ovarian cancer and discovered quantitative features, such as tumor nuclear size on staining with hematoxylin and eosin and omental texture on contrast-enhanced computed tomography, associated with prognosis. We found that these features contributed complementary prognostic information relative to one another and clinicogenomic features. By fusing histopathological, radiologic and clinicogenomic machine-learning models, we demonstrate a promising path toward improved risk stratification of patients with cancer through multimodal data integration.